Company: ZCARW
Filing Date: 2025-03-04
Form Type: S-1
Source: 0001213900-25-020176
Chunk: 100

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-04
Form: S-1
Chunk 100
---
 and the exercise price and the number of shares available for exercise pursuant to the December Series A Warrants are subject to additional adjustments, in the future, as provided below. The December Series B Warrants are exercisable until they are exercised, at an exercise price of $0.0001. On the December Offering Closing Date, the Company issued to the December Selling Holders 3,095,925 shares of Common Stock and Pre-Funded Warrants to purchase 420,000 shares of Common Stock. Selling Holders who purchased Pre-Funded Warrants paid the per share price of $1.56 less $0.0001 for each Pre-Funded Warrant purchased. The Company raised gross proceeds of $5.485 million and after the deduction of fees and expenses payable to the Placement Agent (defined hereafter) and other offering expenses, the net proceeds to the Company was $4.79 million. The December Securities Purchase Agreement contains representations, warranties and covenants of the Company and the Selling Holders customary for this type of transaction. Also, pursuant to the terms of the December Securities Purchase Agreement, the Company is required to hold a special meeting of stockholders (which may also be at the annual meeting of stockholders) at the earliest practicable date after the issuance date, but in no event later than 60 days after the Closing Date for the purpose of obtaining the Stockholder Approval for the exercisability of the December Series A Warrants and the December Series B Warrants and for certain of the provisions included therein, including, adjustments to the exercise price and number of shares issuable upon exercise of the December Series A Warrants following a Dilutive Issuance (as defined in “ Description of Securities”) or Share Combination Event (as defined in “ Description of Securities”) or a reset adjustment under the December Series A Warrants (as described in “ Description of Securities”) and a reset adjustment under the December Series B Warrants (as described in “ Description of Securities”). Stockholder Approval was obtained at a Special Meeting of Stockholders on February 18, 2024. In connection with the December Offering, the Company retained Aegis Capital Corp., pursuant to a Placement Agent Agreement (the “December Offering PAA”) to act as the placement agent (the “Placement Agent”). For acting as the placement agent, the Company agreed to pay the Placement Agent, subject to certain exceptions: (i) a cash fee equal to 10% of the aggregate gross proceeds raised by the Placement Agent in the December Offering (5